Real-World Data on Health-Related Quality of Life Assessment in Patients With Breast Cancer Receiving Subcutaneous Trastuzumab

PURPOSE: Trastuzumab, a humanized anti-human epidermal growth factor receptor 2 (anti-HER2) antibody delivered intravenously, has revolutionized the treatment of patients with breast cancer overexpressing HER2 protein. Recently, a newer subcutaneous formulation was shown to have comparable efficacy...

Descripción completa

Detalles Bibliográficos
Autores principales: Syrios, John, Pappa, Evelina, Volakakis, Nikolaos, Grivas, Anastasios, Alafis, John, Manioudaki, Sofia, Tzouda, Vasiliki, Korogiannos, Athanasios, Rapti, Cleopatra, Koufopoulos, Nektarios, Nikolaidou, Adamantia, Kanavou, Eleftheria, Alexopoulos, Athanasios, Koumarianou, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5826003/
https://www.ncbi.nlm.nih.gov/pubmed/29511355
http://dx.doi.org/10.1177/1178223418758031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5826003/
https://www.ncbi.nlm.nih.gov/pubmed/29511355
http://dx.doi.org/10.1177/1178223418758031

Ejemplares similares